fbpx
Medical Innovation Exchange

Orion's rebooted R&D strategy pays off with $290M Merck deal for prostate cancer drug

https://www.fiercebiotech.com/biotech/orions-rd-new-strategy-pays-ps290m-merck-deal-prostate-cancer-drug

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.